Protective effect of a second booster dose against long COVID among individuals infected with SARS-CoV-2 in southeastern Brazil
COVID-19 vaccination, especially two booster doses, reduced long COVID risk. Female sex, comorbidities, reinfections, and severe acute illness were independent risk factors for developing long-lasting symptoms.
Authors
- Helena Toledo Scheid
- S. Faffe Débora
- S. V. Costa
- Orlando Ferreira (ORCID: https://orcid.org/0000-0002-1970-8936)
- Ana Paula Marchi (ORCID: https://orcid.org/0000-0003-4882-7261)
- Ester Sabino
- Marina Farrel Côrtes (ORCID: https://orcid.org/0000-0003-1925-4855)
- Erika R. Manuli (ORCID: https://orcid.org/0000-0003-2376-8488)
- Mina Ozatha
- Ana Beatriz Miranda Lourenço
- Ana Paula Bandeira Barboza
- Rafael Galliez
- Igor Carmo Borges
- Terezinha Marta Castiñeiras
- Fabio Ghilardi
- Vanderson Sampaio
- Amilcar Tanuri
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Municipal de São Caetano do Sul (BR)
- Hospital Alemão Oswaldo Cruz (BR)
- Instituto de Saúde (BR)
- Instituto Nacional de Câncer - INCA (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Universidade Federal do Pará (BR)
- Pontifícia Universidade Católica de Campinas (BR)
Publication Details
- Journal
- Vaccine
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1016/j.vaccine.2026.128354
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00